Autoplaque vs Viz RV/LV
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is a detailed, quantitative analysis of coronary atherosclerotic plaque and luminal stenoses from CT angiography images. This tool is ideal for comprehensive cardiovascular risk assessment and guiding long-term treatment strategies for coronary artery disease.
View Autoplaque →Choose Viz RV/LV if…
Choose Viz RV/LV if your priority is rapid, automated assessment of right and left ventricular diameters from CTPA scans for acute pulmonary embolism risk stratification. This solution is best suited for urgent care settings where quick identification of PE severity and seamless care team coordination are critical.
View Viz RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Viz RV/LV |
|---|---|---|
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVViz RV/LV (Tool B) offers superior usability due to its cloud-based deployment, mobile DICOM image viewer, and integrated AI-powered alerts and communication platform, enabling flexible and rapid care coordination. Autoplaque (Tool A), being workstation-based, provides detailed analysis but is less adaptable to modern, distributed clinical workflows.
Clinical Value
TieBoth tools provide significant and FDA-cleared clinical value in distinct, critical areas. Autoplaque aids in heart attack risk prediction and treatment guidance through detailed coronary plaque analysis, while Viz RV/LV offers rapid pulmonary embolism risk stratification via automated RV/LV ratio measurements. Their high clinical impact is specialized to different medical contexts.
Pricing & Value
TieNeither Autoplaque nor Viz RV/LV publicly discloses its pricing or offers specific details on their value proposition. Without any information on cost or comparative ROI, it is impossible to determine a winner for this dimension.
Enterprise Readiness
Viz RV/LVViz RV/LV (Tool B) demonstrates stronger enterprise readiness with explicit HIPAA compliance, a Business Associate Agreement (BAA), and a cloud-based deployment that facilitates scalability. Furthermore, Viz.ai provides a comprehensive 'Trust Center' with extensive security and compliance documentation, including SOC 2 Type II and ISO certifications. Autoplaque (Tool A) is workstation-based and lacks specified HIPAA compliance or BAA details in the provided information.
Innovation
Viz RV/LVWhile Autoplaque (Tool A) innovates with AI-powered quantitative plaque characterization and stenosis measurement, Viz RV/LV (Tool B) extends its innovation beyond core image analysis. Its integration into the broader Viz PE Solution, featuring AI-powered alerts, mobile viewing, and a HIPAA-compliant communication platform, represents a more holistic innovation in acute care workflow and coordination.
Support & Docs
Viz RV/LVViz RV/LV (Tool B) offers a robust support infrastructure, including 24/7 urgent phone support, email, in-app support, a knowledge base, user guides, and a dedicated customer success team. Autoplaque (Tool A), developed by a medical center, does not publicly detail a comparable level of dedicated customer support or extensive documentation beyond general mentions in FDA filings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Viz RV/LV |
|---|---|---|
| Name | Autoplaque | Viz RV/LV |
| Company | Cedars-Sinai Medical Center: AIM | Viz.ai |
| Description | Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | Viz RV/LV by Viz.ai is an FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. |
| Key Features | AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement; Analysis of volumetric CTPA acquisitions; AI algorithm for identification and measurement of heart ventricles; Provides annotated images showing ventricular measurements; Seamless component of the Viz PE Solution for suspected pulmonary embolism detection; AI-powered alerts and notifications to care teams; High-fidelity mobile DICOM image viewer; HIPAA-compliant communication platform for care coordination |
| Specialties | Cardiology, Radiology | Emergency Medicine, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Viz RV/LV.